Ajanta Pharma Ltd. - Research Center
532331 AJANTPHARM Group (A) BSE data
Add to watchlist
| Results | |
| Statement |
P&L
|
| More |
Profit loss account
(Rs crore)
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | |
|---|---|---|---|---|---|
| Income | |||||
| Operating income | 3,411.27 | 3,140.64 | 2,718.59 | 2,196.42 | 1,772.62 |
| Expenses | |||||
| Material consumed | 1,071.74 | 887.01 | 767.42 | 698.49 | 432.13 |
| Manufacturing expenses | 65.53 | 54.09 | 43.42 | 38.56 | 32.26 |
| Personnel expenses | 720.41 | 585.87 | 498.11 | 437.82 | 389.37 |
| Selling expenses | 5.02 | 4.78 | 1.62 | 1.40 | 1.34 |
| Adminstrative expenses | 849.29 | 718.00 | 491.11 | 487.37 | 436.31 |
| Expenses capitalised | - | - | - | - | - |
| Cost of sales | 2,711.99 | 2,249.75 | 1,801.68 | 1,663.64 | 1,291.41 |
| Operating profit | 699.28 | 890.89 | 916.91 | 532.78 | 481.21 |
| Other recurring income | 132.75 | 139.73 | 103.57 | 184.20 | 102.15 |
| Adjusted PBDIT | 832.03 | 1,030.62 | 1,020.48 | 716.98 | 583.36 |
| Financial expenses | 5.23 | 9.12 | 6.90 | 9.10 | 0.41 |
| Depreciation | 126.95 | 120.96 | 111.49 | 91.29 | 69.90 |
| Other write offs | - | - | - | - | - |
| Adjusted PBT | 699.85 | 900.54 | 902.09 | 616.59 | 513.05 |
| Tax charges | 141.13 | 180.68 | 226.45 | 171.54 | 121.29 |
| Adjusted PAT | 558.72 | 719.86 | 675.64 | 445.05 | 391.76 |
| Non recurring items | - | - | - | -3.92 | - |
| Other non cash adjustments | - | - | - | - | - |
| Reported net profit | 558.72 | 719.86 | 675.64 | 441.13 | 391.76 |
| Earnigs before appropriation | 3,253.70 | 2,845.69 | 2,241.15 | 1,681.43 | 1,324.73 |
| Equity dividend | 89.69 | 82.21 | 51.26 | 110.96 | 78.85 |
| Preference dividend | - | - | - | - | - |
| Dividend tax | - | - | 31.64 | 2.48 | 0.37 |
| Retained earnings | 3,164.01 | 2,763.48 | 2,158.25 | 1,567.99 | 1,245.51 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis